*ST宇順(002289.SZ)2019年度淨利升108.45%至1303.30萬元
格隆匯4月21日丨*ST宇順(002289.SZ)發佈2019年年度報告,營業收入2.04億元,同比減少36.95%;歸屬於上市公司股東的淨利潤1303.30萬元,同比增長108.45%;歸屬於上市公司股東的扣除非經常性損益的淨虧損7509.21萬元,去年同期則為淨虧損1.54億元;基本每股收益0.0465元。
公司從事智能顯示模組製造,主要為智能POS、智能穿戴、智能家居、車載電子等製造商提供全方位觸控顯示一體化解決方案,為客户提供多形態產品,滿足客户全方位的產品需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.